SNPHY — Stock activity · TradeandTellSNPH
SNPHY
$12.03-$0.14 (-1.19%)live
Held by
0
portfolios on TandT
Avg position size
—
of holders' portfolios
52-week range
$9.22 – $13.93
60% from low
Held by traders on TradeandTell
No one on the platform currently holds SNPHY.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in SNPHY as of their last filing.
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|
| 2015-04-02 | 3-for-2 |
Recent trades on TradeandTell
No one on the platform has traded SNPHY yet.
Insider activity (SEC Form 4)
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Analyst estimates (consensus)
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|
| 2027 | $312.6B | +7.9% | $121.85 | $118.17–$125.64 | 0.1× | 1 |
| 2028 | $331.9B | +6.2% | $150.71 | $146.15–$155.39 | 0.1× | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
DCF fair valuemodel estimate
Peer comparison
| Symbol | Price | Today | Mkt cap | P/E |
|---|
| SNPHYSanten Pharmaceutical Co., Ltd. | $12.03 | -1.19% | $3.9B | — |
| BVNKFBavarian Nordic A/S | $27.69 | +0.00% | $2.1B | — |
| HAWPFHaw Par Corporation Limited | $12.58 | +0.00% | $2.8B | — |
| HAWPYHaw Par Corporation Limited | $53.50 | +0.00% | $3.0B | — |
| MAHLYMediPal Holdings Corporation | $17.37 | +0.00% | $3.6B | — |
| MEPDFMediPal Holdings Corporation | $18.35 | +0.00% | $3.8B |
Source: Financial Modeling Prep · peers by sector/industry
| SDGCFSundrug Co.,Ltd. | $28.18 | +0.00% | $3.3B | — |